about
Stem/Progenitor Cell Niches Involved in Hepatic and Biliary RegenerationVascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanismGABA induces the differentiation of small into large cholangiocytes by activation of Ca(2+) /CaMK I-dependent adenylyl cyclase 8.Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasisAfter damage of large bile ducts by gamma-aminobutyric acid, small ducts replenish the biliary tree by amplification of calcium-dependent signaling and de novo acquisition of large cholangiocyte phenotypes.Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease.Taurocholic acid prevents biliary damage induced by hepatic artery ligation in cholestatic rats.Polycystic liver diseases.Recent advances on the mechanisms regulating cholangiocyte proliferation and the significance of the neuroendocrine regulation of cholangiocyte pathophysiology.Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis.Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis.Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis.Contribution of intestinal smooth muscle to Crohn's disease fibrogenesisNeuropeptide Y inhibits cholangiocarcinoma cell growth and invasion.Role of sex hormones in the modulation of cholangiocyte function.Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor.Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease.Gonadotropin-releasing hormone stimulates biliary proliferation by paracrine/autocrine mechanismsMelatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma: its synthesis is reduced favoring cholangiocarcinoma growthInhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinomaProfiles of cancer stem cell subpopulations in cholangiocarcinomas.Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway.Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in mice‡.Development and functional characterization of extrahepatic cholangiocyte lines from normal rats.Ischemia reperfusion of the hepatic artery induces the functional damage of large bile ducts by changes in the expression of angiogenic factors.Activation of alpha(1) -adrenergic receptors stimulate the growth of small mouse cholangiocytes via calcium-dependent activation of nuclear factor of activated T cells 2 and specificity protein 1.Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease.Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanismsSmall mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway.Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growthNeuropeptide Y inhibits biliary hyperplasia of cholestatic rats by paracrine and autocrine mechanisms.Morphological and functional heterogeneity of the mouse intrahepatic biliary epitheliumTaurocholate feeding to bile duct ligated rats prevents caffeic acid-induced bile duct damage by changes in cholangiocyte VEGF expression.Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expressionRole of hepatic progenitor cells in nonalcoholic fatty liver disease development: cellular cross-talks and molecular networks.New insights into liver stem cells.Recent advances in the morphological and functional heterogeneity of the biliary epitheliumMechanisms of Biliary DamageThe physiological roles of secretin and its receptor.Melatonin inhibits cholangiocyte hyperplasia in cholestatic rats by interaction with MT1 but not MT2 melatonin receptors.
P50
Q26765898-0820EAF4-CC30-43AA-826C-975AB52B47D7Q28573364-FFBFDB66-EFE5-4D4B-9AD8-A632629E23A0Q30542145-A718220C-BB54-4347-BF64-34F559845FD2Q33718790-D12D63D5-32A2-4B4D-BB4E-915E6652F272Q33745195-0F89F758-8F81-4743-BA0B-89CE4699E40EQ33783730-1BA36E61-8A83-47DF-98FC-5731E39ACD34Q33936280-EADDA085-FD69-4F45-AC55-022A7F37621CQ33949172-0B65F297-E27E-46E0-9C7C-AA8288741E96Q34358007-CBCF814F-FE33-4CD9-99DA-255E7A555F66Q34439817-A253C1D7-4F58-4F09-828B-DFBD83BAB796Q34636044-A0F4F4AA-35CF-42CE-967F-A77A7BAA73F6Q34707880-EB4D198F-4068-42E4-91C9-C09155B32AA2Q34905520-858836CB-B887-4AF4-B7D2-4428541996D9Q34979300-22897201-1385-4D80-9294-5F69B63E7BE6Q34992322-522EAB48-6BE0-4F74-87CB-E6406A5B10B0Q35012302-BD306940-069F-4DE9-B091-C0A45B522487Q35088371-10FE8EBB-FFC5-4CBD-A597-358A0A7104D5Q35236464-8AD0055D-E22A-4E70-92C6-669870231555Q35321923-68880575-0D86-459D-9C45-34941A1A812CQ35629462-6441E0CD-FEC4-4778-BCD9-06F5AA149E83Q35669078-F34B380A-DB01-4C1F-9C19-CFCC985A7691Q36054281-86FF8FCD-DDCD-4E87-9F34-3FAC99048DE0Q36136251-A44EBD50-6041-4AA1-AF63-585830CFAE2CQ36219756-00493B22-5581-45F2-AA0E-F2AA24FE2144Q36345910-57B02957-B44B-4400-A631-84D6407A9892Q36466409-6BD6B162-9EFC-438E-98E1-5B23EDDA11C5Q36559639-8EB64E48-A1BD-4F39-A4A3-1C4B6E83B136Q36807790-8938866C-5448-4631-8D52-78EFA94EA321Q36842314-69FC6E67-EEC1-4B2B-BA28-1C4E856CBCB4Q36996185-AF1F026C-2031-4B56-9DAA-12F8C8C2665DQ37093626-24D6A3FE-C54C-49F4-A5FB-B6B5E4D72647Q37142524-3C113257-91F7-40F7-BF7A-ADE74FCEF401Q37157705-489A9284-FED2-4BAA-9421-78DCA2AD74FDQ37253350-C799F948-5837-4939-A73B-CD3096E07439Q37291238-81B6EC63-92ED-48C7-8773-81BD4512E3ABQ37464439-70231EF4-9F5F-4DCD-8049-F62F7915DF53Q37662251-D9A04A5D-23E9-436C-A317-AD082948C2C0Q38038172-443B9AEA-2CEE-46B7-AC7A-09F52CF5C762Q38261684-56CAC022-043C-4724-A2C6-1827348827F8Q38682140-D8C39F3E-7B44-4F84-B4AE-C35A48E89FE9
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paolo Onori
@ast
Paolo Onori
@en
Paolo Onori
@es
Paolo Onori
@nl
Paolo Onori
@sl
type
label
Paolo Onori
@ast
Paolo Onori
@en
Paolo Onori
@es
Paolo Onori
@nl
Paolo Onori
@sl
prefLabel
Paolo Onori
@ast
Paolo Onori
@en
Paolo Onori
@es
Paolo Onori
@nl
Paolo Onori
@sl
P1053
J-9394-2013
P106
P1153
6701535351
P21
P31
P3829
P496
0000-0002-7195-3760